Filing Details
WEST PHARMACEUTICAL SERVICES INC (NYSE:WST) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 23, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNYSE:WST
WEST PHARMACEUTICAL SERVICES INC (WST) Files Quarterly Report for Q0
Filing Details WEST PHARMACEUTICAL SERVICES INC (NYSE:WST) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 23, 2026. The Healthcare…
Market Context
WEST PHARMACEUTICAL SERVICES INC's stock currently trades at $355.48 with a market capitalization of $19.6B.
The 10-Q provides WEST PHARMACEUTICAL SERVICES INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for WEST PHARMACEUTICAL SERVICES INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View WST Stock Page
Frequently Asked Questions
Where can I read WST's SEC filings?
Browse all filings on our WST SEC filings page.
What types of SEC filings does WEST PHARMACEUTICAL SERVICES INC file?
Public companies like WEST PHARMACEUTICAL SERVICES INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
